WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoParasitic infections
Abrir esta carpeta y ver su contenidoInsect and arachnid bites and stings
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Abrir esta carpeta y ver su contenidoSubcutaneous fungal infections
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Abrir esta carpeta y ver su contenidoScaling diseases
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Abrir esta carpeta y ver su contenidoPhotodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Cerrar esta carpetaConditions common in children
Ver el documentoDiaper dermatitis
Ver el documentoHaemangiomas
Ver el documentoMiliaria
Ver el documentoPityriasis alba (patchy hypochromia)
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Abrir esta carpeta y ver su contenidoAntifugal drugs
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Abrir esta carpeta y ver su contenidoScabicides and pediculicides
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Abrir esta carpeta y ver su contenidoMiscellaneous drugs
Abrir esta carpeta y ver su contenidoAnnex
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Pityriasis alba (patchy hypochromia)

Pityriasis alba (patchy hypochromia) affects over 80% of children living in rural areas of developing countries. The disease is characterized by oval or round, scaly, hypochromic lesions in light-exposed areas. Its etiology is obscure. In developed countries, pityriasis alba, which generally is seen with slight scaling, is often a manifestation of atopy (inflammation causes residual hypopigmentation, which is aggravated by the use of topical corticosteroids). In developing countries, skin dryness, nasal discharge and poor hygiene may favour subclinical bacterial proliferation and parakeratosis. These in turn are clinically manifested as fine desquamation and hypochromia.

Management

While hypochromia is only a minor cosmetic problem, it is often perceived as a health priority. Management should be addressed first to explaining the nature of the disease and its lack of relation to other common conditions in developing countries such as vitamin deficiencies, intestinal parasite infections or other infections. It is also necessary to point out that the disease itself is not contagious. Emollients can be prescribed. In developing countries, a topical preparation consisting of 60% petroleum jelly and 40% zinc oxide with 2% clioquinol powder and 0.5% coal tar is used for this condition. The preparation should be applied at night and washed off in the morning. Treatment usually has to be maintained for 4-6 weeks.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012